Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
DB0614 is a proteolysis-targeting chimera (PROTAC) containing a kinase-binding thienopyrimidine compound conjugated with the cereblon (CRBN) ligand thalidomide via an alkyl linker.1 It reduces the levels of seven kinases, NIMA-related kinase 9 (NEK9), Cdk4 and -6, AP2-associated protein kinase 1 (AAK1), proline-rich tyrosine kinase 2 (PYK2), serine/threonine kinase 17a (STK17A), and WEE1 greater than two-fold in MOLT-4 human T cell lymphoblasts at a concentration of 125 nM.
WARNING This product is not for human or veterinary use.
1. Synthesis and structure-